Prevention and Treatment of Functional and Structural Radiation Injury in the Rat Heart by Pentoxifylline and Alpha-Tocopherol

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 1, 2008, Pages 170-177

  Boerma, Marjan ^a   Roberto, Kerrey A ^a   Hauer Jensen, Martin ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Tocopherol; Fibrosis; Heart; Pentoxifylline; Radiation

Indexed keywords

ARSENIC COMPOUNDS; BLOOD PRESSURE; CHLORINE COMPOUNDS; ELECTROTHERAPEUTICS; HEALTH; IRRADIATION; MERCURY (METAL); RATS; WEIGHT CONTROL;

DIASTOLIC PRESSURE; FIBROSIS; HEART; HEART DISEASES; LEFT VENTRICULAR; PENTOXIFYLLINE; RADIATION INJURIES; RAT HEARTS; RAT MODELS; SHAM-IRRADIATION; SIDE EFFECTS; SPRAGUE-DAWLEY RATS;

RADIATION;

ALPHA TOCOPHEROL; PENTOXIFYLLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBROBLAST; HEART INJURY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART WEIGHT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION INJURY; RAT;

ALPHA-TOCOPHEROL; ANIMALS; CELL COUNT; COLLAGEN TYPE I; COLLAGEN TYPE III; CYTOSKELETON; DIASTOLE; FIBROSIS; HEART; MALE; MAST CELLS; MYOCARDIUM; PENTOXIFYLLINE; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 49549099978     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.042     Document Type: Article

References (31)

1. Aleman B.M., van den Belt-Dusebout A.W., Klokman W.J., et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21 (2003) 3431-3439
2. Hooning M.J., Aleman B.M., van Rosmalen A.J., et al. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys 64 (2006) 1081-1091
3. Darby S.C., McGale P., Taylor C.W., et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6 (2005) 557-565
4. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994) 447-453
5. Early Breast Cancer Trialists Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 355 (2000) 1757-1770
6. Heidenreich P.A., Hancock S.L., Vagelos R.H., et al. Diastolic dysfunction after mediastinal irradiation. Am Heart J 150 (2005) 977-982
7. Okunieff P., Augustine E., Hicks J.E., et al. Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol 22 (2004) 2207-2213
8. Hille A., Christiansen H., Pradier O., et al. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181 (2005) 606-614
9. Delanian S., Porcher R., Rudant J., et al. Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 23 (2005) 8570-8579
10. Gothard L., Cornes P., Earl J., et al. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. Radiother Oncol 73 (2004) 133-139
11. Zywietz F., Bohm L., Sagowski C., et al. Pentoxifylline enhances tumor oxygenation and radiosensitivity in rat rhabdomyosarcomas during continuous hyperfractionated irradiation. Strahlenther Onkol 180 (2004) 306-314
12. Vernimmen F., Verheye-Dua F., du Toit H., et al. Effect of pentoxifylline on radiation damage and tumor growth. Strahlenther Onkol 170 (1994) 595-601
13. Boerma M., Zurcher C., Esveldt I., et al. Histopathology of ventricles, coronary arteries and mast cell accumulation in transverse and longitudinal sections of the rat heart after irradiation. Oncol Rep 12 (2004) 213-219
14. Boerma M., Wang J., Wondergem J., et al. Influence of mast cells on structural and functional manifestations of radiation-induced heart disease. Cancer Res 65 (2005) 3100-3107
15. Radke M.H., Peng J., Wu Y., et al. Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy. Proc Natl Acad Sci U S A 104 (2007) 3444-3449
16. Boerma M., Fiser W.P., Hoyt G., et al. Influence of mast cells on outcome after heterotopic cardiac transplantation in rats. Transpl Int 20 (2007) 256-265
17. James J.D., and Hauer-Jensen M. Effects of fixative and fixation time for quantitative computerized image analysis of immunohistochemical staining. J Histotechnol 22 (2001) 109-111
18. Richter K.K., Langberg C.W., Sung C.C., et al. Association of transforming growth factor beta (TGF-beta) immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy. Radiother Oncol 39 (1996) 243-251
19. Rajendran R., Rani V., and Shaikh S. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res 17 (2006) 190-198
20. Desmouliere A., Xu G., Costa A.M., et al. Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells. J Hepatol 30 (1999) 621-631
21. Hung K.Y., Huang J.W., Chen C.T., et al. Pentoxifylline modulates intracellular signalling of TGF-beta in cultured human peritoneal mesothelial cells: Implications for prevention of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 18 (2003) 670-676
22. Fang C.C., Yen C.J., Chen Y.M., et al. Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: Effects on TGF-beta. Kidney Int 57 (2000) 2626-2633
23. Lin S.L., Chen R.H., Chen Y.M., et al. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. J Am Soc Nephrol 16 (2005) 2702-2713
24. Martin M., Lefaix J., and Delanian S. TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target?. Int J Radiat Oncol Biol Phys 47 (2000) 277-290
25. Vozenin-Brotons M.C., Milliat F., Sabourin J.C., et al. Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression. Int J Radiat Oncol Biol Phys 56 (2003) 561-572
26. Lefaix J.L., Delanian S., Vozenin M.C., et al. Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: an experimental study. Int J Radiat Oncol Biol Phys 43 (1999) 839-847
27. Kruse J.J., Bart C.I., Visser A., et al. Changes in transforming growth factor-beta (TGF-beta1), procollagen types I and III mRNA in the rat heart after irradiation. Int J Radiat Biol 75 (1999) 1429-1436
28. Seigneur M., Dufourcq P., Belloc F., et al. Influence of pentoxifylline on membrane thrombomodulin levels in endothelial cells submitted to hypoxic conditions. J Cardiovasc Pharmacol 25 Suppl 2 (1995) S85-S87
29. Normandin L., Herve P., Brink C., et al. L-arginine and pentoxifylline attenuate endothelial dysfunction after lung reperfusion injury in the rabbit. The Paris-Sud University Lung Transplant Group. Ann Thorac Surg 60 (1995) 646-650
30. Wang J., Boerma M., Fu Q., et al. Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. World J Gastroenterol 13 (2007) 3047-3055
31. Hinz B., and Gabbiani G. Mechanisms of force generation and transmission by myofibroblasts. Curr Opin Biotechnol 14 (2003) 538-546